Kelmendi, Benjamin

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial

Raison, C. L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B. W., Brown, R. T., Kakar, R., Hassman, M., Trivedi, R. P., Robison, R., et al. (2023) · JAMA

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 545

Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients

Laje, G., Lally, N., Mathews, D., Brutsche, N., Chemerinski, A., Akula, N., Kelmendi, B., Simen, A., McMahon, F. J., Sanacora, G., et al. (2012) · Biological Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 213

KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS

Abdallah, C. G., Adams, T. G., Kelmendi, B., Esterlis, I., Sanacora, G., & Krystal, J. H. (2016) · Depression and Anxiety

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 206

Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic

Krystal, J. H., Abdallah, C. G., Averill, L. A., Kelmendi, B., Harpaz-Rotem, I., Sanacora, G., Southwick, S. M., & Duman, R. S. (2017) · Current Psychiatry Reports

Posttraumatic Stress Disorder ResearchTreatment of Major Depression

Cited by 145

LONG-TERM OUTCOME IN ADULTS WITH OBSESSIVE-COMPULSIVE DISORDER: Research Article: Long-Term Outcome in Adult OCD

Bloch, M. H., Green, C., Kichuk, S. A., Dombrowski, P. A., Wasylink, S., Billingslea, E., Landeros-Weisenberger, A., Kelmendi, B., Goodman, W. K., Leckman, J. F., et al. (2013) · Depression and Anxiety

Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 94

A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder

Barsuglia, J. P., Polanco, M., Palmer, R., Malcolm, B. J., Kelmendi, B., & Calvey, T. (2018) · Progress in Brain Research

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 38

Toward understanding the heterogeneity in obsessive-compulsive disorder: Evidence from narratives in adult patients

Van Schalkwyk, G. I., Bhalla, I. P., Griepp, M., Kelmendi, B., Davidson, L., & Pittenger, C. (2016) · Australian & New Zealand Journal of Psychiatry

Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 29

Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: Protocol for a randomized, double-blind, placebo-controlled, non-crossover trial

Ching, T. H. W., Grazioplene, R., Bohner, C., Kichuk, S. A., DePalmer, G., D’Amico, E., Eilbott, J., Jankovsky, A., Burke, M., Hokanson, J., et al. (2023) · Frontiers in Psychiatry

Psychedelics and Drug StudiesObsessive-Compulsive Spectrum Disorders

Cited by 29

Yale program for psychedelic science (YPPS) manual for psilocybin combined with non-directive support in the treatment of OCD

Ching, T. H. W., Grazioplene, R., Pittenger, C., & Kelmendi, B. (2023)

Psychedelics and Drug StudiesObsessive-Compulsive Spectrum Disorders

Cited by 6